Compare the Therapeutic Effect Treated With Tamsulosin and Progesterone After ESWL( Extra Corporeal Shock Wave Lithotripsy) in Urinary Calculus
The purpose of this study is to compare the stone clearance rate treated with different drugs after ESWL in urinary calculus,These drugs are often used in urinary calculus,such as progesterone,tamsulosin,propantheline Bromide and nifedipine.In these study the investigators want to investigate different effect of these drugs use to treat urinary calculus after ESWL...
Brief Summary
Official Title: “the Therapeutic Effect Treated With Tamsulosin After ESWL in Urinary Calculus”
The purpose of this study is to compare the stone clearance rate treated with different drugs after ESWL in urinary calculus,These drugs are often used in urinary calculus,such as progesterone,tamsulosin,propantheline Bromide and nifedipine.In these study the investigators want to investigate different effect of these drugs use to treat urinary calculus after ESWL.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
- Study Primary Completion Date: October 2009
Detailed Clinical Trial Description
There is 4 groups in these investigation, group1 urinary calculus treated with ESWL only ,group2 urinary calculus treated with ESWL and tamsulosin,group3 urinary calculus treated with ESWL and progesterone,group4 urinary calculus treated with ESWL ,propantheline Bromide and nifedipine.We want to investigate which one is better or not in urinary calculus treated with ESWL .
Intervention(s) in this Clinical Trial
- Drug: progesterone,tamsulosin,propantheline Bromide and nifedipine
- clearance rate of stone
Arms, Groups and Cohorts in this Clinical Trial
- Experimental: progesterone,tamsulosin,propantheline Bromide and nifedipine
- different effect of these drugs use to treat urinary calculus after ESWL
Outcome Measures for this Clinical Trial
Primary Measures
- different effect of these drugs use to treat urinary calculus after ESWL
- Time Frame: 2weeks
Safety Issue?: Yes
- Time Frame: 2weeks
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- From 18 years old to 68 years old,
- urinary calculus could be treated by ESWL,
- the calculus size is from 4-25mm
Exclusion Criteria:
- Less than 18 years old or more than 68 years old,
- the calculus size is from Less than4 or larger than 25mm
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: 68 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers
Clinical Trial Investigator Information
Lead Investigator: Chongqing Medical University Other
Overall Clinical Trial Officials and Contacts
xiaohou wu, doctor Study Chair The first affiliated hospital, Chongqing medical university
Overall Contact: Yunfeng He, Doctor 86-23-89011121
Additional Information
Information obtained from ClinicalTrials.gov on February 09, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT01010048
Study ID Number: CQMU
ClinicalTrials.gov Identifier: NCT01010048
Health Authority: China: State Food and Drug Administration
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT01010048
